Atlas Trials

Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)

Clinical trial NCT02597361 · COMPLETED

Trial details

NCT number
NCT02597361
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ehlers-Danlos Syndrome, Vascular Type
Start date
2016-01-01
Primary completion
2020-02-19
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.